Skip to content

Gross Profit at other companies

Abbott logo
AbbottABT
$6.27B+6.5%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$15.96B+9.8%
Boston Scientific logo
Boston ScientificBSX
$3.61B+12.6%
Medtronic logo
MedtronicMDT
$6.41B+10.9%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$184.8M+7.4%
ITG
Integer HoldingsITGR
$109.6M-8.9%

Other financials

Income statement

See full
Revenue$401.0K
Operating income-$19.2M-6.1%
Net income-$18.6M-10.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$68.3M-42.7%
Total debt$7.2M-16.6%
Total equity$66.3M-44.0%
Total assets$81.6M-38.8%

Cash flow

See full
Operating cash flow-$14.6M-7.9%
CapEx$33.0K-26.7%
Free cash flow-$14.6M-7.8%

Valuation

See full
Market cap$1.8B+38.4%
Enterprise value$1.73B+48.1%
P/S2,391.5×

Profitability

See full
Gross margin-4,067.5%
Operating margin-10,392.1%
Net margin-9,929%
FCF margin-7,390%

Returns & leverage

See full
Return on equity-80.7%+3.1pp
Debt / equity0.1×0.0×
Current ratio7.3×-8.3×

Where this comes from

Calculated from Pulse Biosciences, Inc.’s reported figures.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s gross profit?
Pulse Biosciences, Inc. (PLSE) reported gross profit of $31K in Q1 2026.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.